EisnerAmper Hosts Forbes’ “30 Under 30” Life Sciences Entrepreneur

Over 50 life science CEOs, CFOs, investors and industry experts came to our ‘Rising from the Ashes: The Axovant Sciences Story’ fire-side chat at the Cornell Club in mid-town Manhattan. The guest speaker was Vivek Ramaswamy, a 31-year-old former hedge fund manager who led the largest-ever IPO of a biotech company, Axovant Sciences, in 2015—and was recently featured in Forbes’ ‘Boy in the Bubble’ cover story.

It’s no secret that biotechnology and innovation have been booming in New York City and across the state. New York is ever-increasingly becoming a hub for biotech growth as startups see more funding, partnership opportunities and accelerator programs. 

When partner John Pennett asked Mr. Ramaswamy about success, the young entrepreneur mentioned that “professional skepticism” learned earlier in his career as a hedge fund manager helped him ask the tough questions required to eventually position his startup, Axovant Sciences, for success.